The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal
Top Cited Papers
- 15 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 203 (2) , 168-174
Abstract
Subclinical tuberculosis includes disease forms that are detectable by radiographic or microbiological assays but do not cause recognizable symptoms. Population-based prevalence surveys demonstrate that the majority of individuals with culture-positive tuberculosis and corresponding radiographic abnormalities lack recognizable symptoms. Subclinical tuberculosis is often conceptualized as an early stage that generally progresses to recognizable active tuberculosis disease within months. However, many individuals with subclinical tuberculosis likely never develop recognizable symptoms, and consequently are never identified as having tuberculosis. A growing body of evidence indicates that, in high-burden settings, people with tuberculosis spend more time in a subclinical state than they spend with recognizable symptoms, and that people with subclinical tuberculosis may be infectious. As such, the subclinical period may represent a long window of potential Mycobacterium tuberculosis transmission. To appropriately prioritize interventions, there is a need to quantify the amount of transmission that occurs during the subclinical period, including the contribution of those who never develop clinically symptomatic disease. If individuals with subclinical tuberculosis are responsible for a large fraction of M. tuberculosis transmission, then ambitious reductions in tuberculosis incidence cannot be achieved without greater focus on early detection and treatment of subclinical tuberculosis. Novel diagnostic assays, population-based studies, and bioinformatic techniques could be used to better estimate the contribution of individuals with subclinical tuberculosis to overall transmission. This knowledge can help us understand whether finding and treating people with subclinical tuberculosis is essential or extraneous as part of a comprehensive strategy to end the epidemic.Keywords
This publication has 44 references indexed in Scilit:
- Cough frequency in health and diseaseEuropean Respiratory Journal, 2012
- Variability of Infectious Aerosols Produced during Coughing by Patients with Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional StudyPLOS Medicine, 2012
- Detection and treatment of subclinical tuberculosisTuberculosis, 2012
- Screening Strategies for Tuberculosis Prevalence Surveys: The Value of Chest Radiography and SymptomsPLOS ONE, 2012
- Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individualsAIDS, 2011
- Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic ReviewPLOS ONE, 2011
- Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literatureBMC Infectious Diseases, 2009
- Mycobacterium tuberculosis Miniepidemic in a Church Gospel ChoirChest, 1998
- An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992